Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Reported Issues: Consumers report: That the supplement did not lead to weight loss or appetite suppression as advertised That the product was marketed using misleading claims about GLP-1 support That they paid for a product that did not provide the promised benefits That the supplements are promoted as alternatives to GLP-1 medications, despite not functioning like prescription GLP-1 drugs That marketing materials imply that these supplements are scientifically and medically proven and reliable, when evidence may be lacking That they would not have purchased the supplements if they had known the claims were not supported by reliable scientific evidence Experiencing adverse side effects such as stomach pain or bloating Why Individuals Should Be Concerned: Potential claims include: Economic loss False advertising Safety risk Product defect Performance vs
The short answer is no, CJC 1295 and Ipamorelin are not approved by the FDA for general medical use
Immunohistochemical staining of ST2, Vimentin, and E-cadherin
Viral and bacterial infections can also lead to a rash on the stomach
US$ 27.43
US$ 21.17
US$ 21.72
US$ 22.73
